Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Verbeek, A. L. M.
Right arrow Articles by Broeders, M.J.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verbeek, A. L. M.
Right arrow Articles by Broeders, M.J.M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 14:1203-1205, 2003
© 2003 European Society for Medical Oncology

Original Paper

Evaluation of The Netherlands breast cancer screening programme

A. L. M. Verbeek+ and M.J.M. Broeders

Department of Epidemiology and Biostatistics, University Medical Centre Nijmegen, Nijmegen, The Netherlands

Received 5 July 2002; accepted 3 April 2003

The Netherlands breast cancer screening programme for women aged 50–75 years was gradually implemented during 1989–1997. Short-term indicators for this mammography screening are 80% attendance (800 000 examinations yearly), and for the subsequent screening examinations 7.4 referrals for clinical assessment per 1000 women screened, 4.7 biopsies and 3.6 breast cancers detected. Breast cancer mortality in The Netherlands has been decreasing since 1997 after having been stable for decades. The challenge now is to disentangle the relative contributions of mammographic screening, earlier clinical diagnosis, less aggressive tumours, treatment advances and risk factors towards this decline.

Key words: breast cancer service screening, evaluation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
P. Boyle
Global summit on mammographic screening
Ann. Onc., August 1, 2003; 14(8): 1159 - 1160.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.